evorion biotechnologies GmbH

www.evorion.de

A pioneer in functional phenomics, evorion biotechnologies offers a proprietary multiparametric platform to characterize thousands of cell-cell interactions at single-cell resolution. Current single-cell multi-omics technologies are an invaluable tool for biological research and precision medicine but fail to directly link a single cell's multi-omics data to changes in its functional phenotype over time. This is where our innovative chip-based technology excels. For the first time, researchers can simultaneously analyze multiple phenotypes (cellular functions, intracellular protein expression, surface, and secreted protein profiles) and the cellular interactions of thousands of cell pairs in a highly parallelized manner. They can then couple those insights directly to each cell’s underlying genetic and transcriptional makeup, merging functional phenotypes with multi-omics data. Our technologies and services are designed to comprehensively analyze biological systems over time and space, and at the resolution of the smallest unit of life. We aim to improve human health by answering unresolved questions with high-end tools and services that reveal novel single-cell mechanistic insights in the field of cell-based therapies, oncology, infectious disease, immunology, and regenerative medicine. Partnering with academia and industry, we enable the research breakthroughs today that will translate to the therapies of tomorrow.

Read more

Reach decision makers at evorion biotechnologies GmbH

Lusha Magic

Free credit every month!

A pioneer in functional phenomics, evorion biotechnologies offers a proprietary multiparametric platform to characterize thousands of cell-cell interactions at single-cell resolution. Current single-cell multi-omics technologies are an invaluable tool for biological research and precision medicine but fail to directly link a single cell's multi-omics data to changes in its functional phenotype over time. This is where our innovative chip-based technology excels. For the first time, researchers can simultaneously analyze multiple phenotypes (cellular functions, intracellular protein expression, surface, and secreted protein profiles) and the cellular interactions of thousands of cell pairs in a highly parallelized manner. They can then couple those insights directly to each cell’s underlying genetic and transcriptional makeup, merging functional phenotypes with multi-omics data. Our technologies and services are designed to comprehensively analyze biological systems over time and space, and at the resolution of the smallest unit of life. We aim to improve human health by answering unresolved questions with high-end tools and services that reveal novel single-cell mechanistic insights in the field of cell-based therapies, oncology, infectious disease, immunology, and regenerative medicine. Partnering with academia and industry, we enable the research breakthroughs today that will translate to the therapies of tomorrow.

Read more
icon

Country

icon

City (Headquarters)

Münster

icon

Employees

11-50

icon

Founded

2017

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chairman of the Supervisory Board

    Email ****** @****.com
    Phone (***) ****-****
  • Chairman of the Supervisory Board

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(5)

Reach decision makers at evorion biotechnologies GmbH

Free credits every month!

My account

Sign up now to uncover all the contact details